Drug Profile
Research programme: peptide therapeutics - KeyBioscience
Alternative Names: KBP-056Latest Information Update: 28 Aug 2022
Price :
$50
*
At a glance
- Originator KeyBioScience
- Class Peptides
- Mechanism of Action Amylin receptor agonists; Calcitonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Metabolic disorders